Date Range
Date Range
Date Range
Genomic Health does not give treatment for cancer or advise patients on their treatment plans. Anyone in doubt about their own health or cancer should seek medical advice from a qualified healthcare professional. Oncotype DX for Breast Cancer. Oncotype DX for Prostate Cancer. Oncotype DX for Colon Cancer.
Redwood City, CA, CA. Remote - Anywhere in US, Kansas. Life, changingCHOICE, CULTURE, CAREER. Helping cancer patients create a personalized treatment has its rewards on many levels throughout the company.
Additional Oncotype DX Assay-Related Articles. Quantitative Single Gene Reporting-Related Articles. Presentations, Posters and Abstracts. Transforming the Treatment of Cancer.
Genomic Health and Oncotype DX 10 Years and Beyond. Watch how Genomic Health will continue to shape a world in which genomic information is truly life, changing. Oncotype DX for Breast Cancer.
Genoptix is a leading specialized laboratory service provider focused on delivering personalized and comprehensive diagnostic services to its physician customers, community-based hematologists and oncologists. Its diagnostic services are designed to optimize the care of patients suffering.
Code of Business Conduct and Ethics. 2017 Annual Meeting Of Stockholders Results. 2017 Special Meeting Of Stockholders Results. Welcome to Genworth Investor Relations. Genworth remains committed to helping families become more financially secure, self-reliant and prepared for the future.
Annual General Meeting of Shareholders. Risk, Capital and Investment Committee. March 5, 2018 -. February 6, 2018 -.
EndoBarrier is not approved for sale in the United States and is limited by federal law to investigational use only in the United States. Founded in 2003, GI Dynamics is headquartered in Boston, Massachusetts. Enter the code shown above. Email Alert Sign Up Confirmation.
Advanced Signal Control Software Suite. Advanced Signal Control Software Suite. Quarter Ended Dec 30, 2017. Quarter Ended Dec 30, 2017.